SecBot SecBot
144 ·Filed Jun 3, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001950047-26-005601
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Traders should monitor for any negative catalyst or guidance revision that may have prompted the selling.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$51.67
T+0 close · Jun 3, 2026 · via day close
Latest settled
+8.92%
T+60 · $56.28
Vs SPY
+7.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $51.67entry
  2. T+1 · 6mo ago −2.52%α +0.08% · $50.37
  3. T+5 · 5mo ago +4.97%α +7.53% · $54.24
  4. T+20 · 4mo ago +22.74%α +24.11% · $63.42
  5. T+60 · 3mo ago +8.92%α +7.04% · $56.28

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Dennis Mulroy filed a Form 144 to sell 20,000 shares (~$1.0M at filing) via a stock option exercise, signaling intent to sell. This follows a heavy selling pattern: Mulroy has sold ~127,422 shares worth ~$7.5M over the prior two weeks (May 15–June 2), including 10,000–15,000 share blocks nearly every trading day.

Key Facts

  • CEO Dennis Mulroy filed Form 144 to sell 20,000 shares via stock option exercise, with an estimated market value of ~$1,017,250.
  • Mulroy has sold ~127,422 shares worth ~$7.5M in the 15 trading days prior (May 15–June 2), including daily blocks of 10,000–15,000 shares.
  • The filing is an advance notice of intent to sell; the actual sale may or may not occur, but the pattern of persistent insider selling is notable.
  • No cross-filing context (earnings, M&A, or other material events) was provided to explain the selling.

Financial Impact

CEO selling ~$1.0M in this notice, with ~$7.5M sold in the prior two weeks; total insider sales represent a small fraction of the $1.5B market cap but are concentrated and persistent.

insider sellingdilution

Risk Factors

  • CEO selling may signal lack of confidence in near-term prospects or upcoming negative news.
  • Heavy insider selling could pressure the stock price as the market interprets the pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005601
Document: 0001950047-26-005601-index.html0001950047-26-005601
Document: 0001950047-26-005601.txt0001950047-26-005601

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026